Abstract
Toxoplasma has become a well-recognized cause of disease in the last decade, primarily due to the prominence of AIDS. Diagnosis of toxoplasmic encephalitis is discussed, with emphasis on serologic tests, their pitfalls, and empiric therapeutic trials. Randomized trials for treatment of toxoplasmic encephalitis are few, but the combinations of pyrimethamine and sulfadiazine and of pyrimethamine and clindamycin appear comparable. Needs and methods for specific prophylaxis of toxoplasmic encephalitis are not well defined. It is now feasible to diagnose Toxoplasma infection in utero with a high degree of sensitivity and specificity, but whether such diagnosis is effective in the usual practice situation in the United States remains to be proved. Toxoplasmosis in transplant recipients is reviewed briefly.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
